greeksoup/ stock research

Chemours (CC) FY2022 results: revenue $6.8 billion, up 7.7% on the year

Chemours Co. (CC) reported revenue of $6.8 billion for fiscal 2022, the year ended 31 December 2022, up 7.7% on the year before. Net income was $578 million, down 4.9%, and diluted earnings per share $3.65. The figures are the company's own, from the 10-K it filed with the SEC on 10 February 2023.

Revenue
$6.8 billion
+7.7% on the year
FY2015FY2022
Operating margin
11.3%
10.7% a year earlier
FY2015FY2022
Net income
$578 million
-4.9% on the year
FY2015FY2022
Diluted EPS
$3.65
+1.4% on the year
FY2015FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2022 · Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue6,8316,3454,969+7.7%
Cost of revenue5,2154,9643,902+5.1%
Gross profit1,6161,3811,067+17.0%
Gross margin23.7%21.8%21.5%
Research and development11810793.0+10.3%
Selling, general and administrative710592527+19.9%
Operating income772676367+14.2%
Operating margin11.3%10.7%7.4%
Interest expense163185210-11.9%
Pre-tax income741676179+9.6%
Income tax16368.0-40.0+139.7%
Effective tax rate22.0%10.1%-22.3%
Net income578608219-4.9%
Net margin8.5%9.6%4.4%
Diluted EPS$3.65$3.60$1.32+1.4%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow754814807-7.4%
Capital expenditure307277267+10.8%
Free cash flow447537540-16.8%
Free cash flow margin6.5%8.5%10.9%
Cash from investing-284220-234
Cash from financing-685-554-449
Depreciation and amortisation291317320-8.2%
Share-based compensation27.034.016.0-20.6%
Buybacks4951730.0+186.1%
Dividends paid154164164-6.1%
Dividend per share$1.00$1.00$1.000.0%
Diluted shares, weighted158m169m166m-6.2%
Shares outstanding at period end149m161m165m-7.8%

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity1,1071,081813+2.4%
Non-controlling interestn/a1.02.0
Debt3,6333,7494,026-3.1%
Operating lease liabilities198179194+10.6%
Finance lease liabilities49.060.067.0-18.3%
Other liabilities2,6532,4801,980+7.0%
Total liabilities and equity7,6407,5507,082+1.2%
Fixed assets3,1713,1543,474+0.5%
Goodwill1021021530.0%
Intangible assets13.06.014.0+116.7%
Cash and equivalents1,1021,4511,105-24.1%
Receivables509644449-21.0%
Inventory1,4041,099939+27.8%
Other assets1,3391,094948+22.4%
Total assets7,6407,5507,082+1.2%

10-K for the year ended 31 December 2022, filed 10 February 2023: the filing.